Skip to main content
Cabozantinib gains ground for salvage in differentiated thyroid cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Cabozantinib gains ground for salvage in differentiated thyroid cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Thyroid Cancer
1
0.97
Toxicology
0
0.84
Thyroid
0
0.74
Thyroid Disease
0
0.74
Hepatocellular Carcinoma
0
0.48
Liver Metastases
0
0.43
Cancer
0
0.42
Biologic Therapy
0
0.41
Metastasis
0
0.41
Targeted Cancer Therapy
0
0.41
Brachial
0
0.21
Refractory
0
0.21
Biomarker
0
0.11
Bone
0
0.11
Dermatitis
0
0.11
Diarrhea
0
0.11
Fatigue
0
0.11
Grant
0
0.11
Hand
0
0.11
Hypertension
0
0.11
Id Reaction
0
0.11
Liver
0
0.11
Nausea
0
0.11
Pedal
0
0.11
Pennsylvania
0
0.11
Quality of Life
0
0.11
Receptors
0
0.11
Vascular Endothelial Growth Factor (VEGF)
0
0.11
Specialty
Lead
score
Hematology-Oncology
1
1
Diabetes & Endocrinology
0
1
Emergency Medicine
0
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Public Health & Prevention
0
0.96
Gastroenterology
0
0.75
Pharmacist
0
0.56
Dermatology
0
0.48
Cardiology
0
0.26